Indivior PLC (INDV)
NASDAQ: INDV · Real-Time Price · USD
30.10
-0.97 (-3.12%)
At close: Nov 12, 2025, 4:00 PM EST
30.10
0.00 (0.00%)
After-hours: Nov 12, 2025, 4:00 PM EST
Indivior Employees
As of December 31, 2024, Indivior had 1,051 total employees, including 1,030 full-time and 21 part-time employees. The number of employees decreased by 113 or -9.71% compared to the previous year.
Employees
1,051
Change (1Y)
-113
Growth (1Y)
-9.71%
Revenue / Employee
$1,122,740
Profits / Employee
$70,409
Market Cap
3.76B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,051 | -113 | -9.71% |
| Dec 31, 2023 | 1,164 | 236 | 25.43% |
| Dec 31, 2022 | 928 | 43 | 4.86% |
| Dec 31, 2021 | 885 | 97 | 12.31% |
| Dec 31, 2020 | 788 | -8 | -1.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
INDV News
- 9 days ago - Indivior Presents New Real-World Evidence at AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine - PRNewsWire
- 13 days ago - Indivior PLC (INDV) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Indivior Reports Third Quarter 2025 Financial Results and Raises Full-Year 2025 Financial Guidance - PRNewsWire
- 15 days ago - Indivior to Participate in the Stifel 2025 Healthcare Conference - PRNewsWire
- 27 days ago - Indivior to Report Third Quarter 2025 Financial Results and Host Webcast on October 30th - PRNewsWire
- 4 weeks ago - Clinical Evidence Supports Rapid SUBLOCADE® Induction as a Strategy to Improve Retention in Opioid Use Disorder Treatment - PRNewsWire
- 6 weeks ago - UK's Indivior to re-domicile to US after listing move - Reuters
- 6 weeks ago - Indivior Proposes New Corporate Structure to Achieve U.S. Domiciliation - PRNewsWire